Palatin Technologies PTN
NASDAQ PTN
$12.02 -0.31 (-2.51%)
At close: Sep 10, 2026 · 4:00 PM EDT

Palatin Technologies (PTN) Net Cash Flow (2010 - 2026)

Palatin Technologies' (PTN) quarterly Net Cash Flow came in at -$4.3 million in Q1 2026, down 381.48% on a YoY basis from $1.5 million in Q1 2025, and down 132.66% quarter-over-quarter from $13.2 million in Q4 2025.

Analysis

Palatin Technologies (PTN) Net Cash Flow (2010 - 2026) Analysis & Trends

Palatin Technologies (PTN) has reported Net Cash Flow for 17 consecutive years, with -$4.3 million the latest figure, recorded in Q1 2026.

  • For the quarter ending Q1 2026, Net Cash Flow fell 381.48% year-over-year to -$4.3 million; the trailing twelve-month figure through Mar 2026 stood at $7.7 million (up 202.11% YoY), and the FY2025 full-year result was -$7.0 million, down 552.79% from the prior year.
  • Net Cash Flow eased to -$4.3 million in Q1 2026 per PTN's latest filing, from $13.2 million in the prior quarter.
  • Across five years, Net Cash Flow topped out at $13.2 million in Q4 2025 and bottomed at -$11.6 million in Q2 2023.
  • Historically, Net Cash Flow has averaged -$2.2 million across 5 years, with a median of -$1.3 million in 2025.
  • The sharpest annual moves came in 2023 and 2026: Net Cash Flow jumped 43927.79% in 2023, then tumbled 381.48% in 2026.
  • Over 5 years, Net Cash Flow stood at -$9036.0 in 2022, then surged by 43927.79% to $4.0 million in 2023, then plunged by 73.93% to $1.0 million in 2024, then jumped by 1180.13% to $13.2 million in 2025, then slumped by 132.66% to -$4.3 million in 2026.
  • According to Business Quant data, Net Cash Flow over the past three periods registered -$4.3 million, $13.2 million, and -$1.3 million for Q1 2026, Q4 2025, and Q3 2025 respectively.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Net Cash Flow (Qtr)
1 Amgen 206.44 Bn 192.45 Bn 7.24 Bn 1.95 Bn
2 Gilead Sciences 179.97 Bn 176.79 Bn 6.22 Bn -4.43 Bn
3 Vertex Pharmaceuticals 130.57 Bn 122.72 Bn 2.84 Bn 652.90 Mn
4 Regeneron Pharmaceuticals 81.63 Bn 73.63 Bn 3.93 Bn -504.30 Mn
5 Argenx Se 60.34 Bn 55.16 Bn 1.37 Bn -
6 Moderna 54.37 Bn 49.23 Bn 52.00 Mn -183.00 Mn
7 Alnylam Pharmaceuticals 33.07 Bn 29.76 Bn 992.69 Mn -496,000.00
8 Biogen 31.84 Bn 30.55 Bn 1.96 Bn -2.09 Bn
9 Roivant Sciences 29.49 Bn 29.49 Bn 1.16 Mn -170.75 Mn
10 Palatin Technologies 46.98 Mn 46.98 Mn - -4.32 Mn
Historic Data

Historic Data

Download Data
DateValue
Mar 31, 2026 -4.32 Mn
Dec 31, 2025 13.22 Mn
Sep 30, 2025 -1.29 Mn
Jun 30, 2025 44,203.00
Mar 31, 2025 -896,542.00
Dec 31, 2024 1.03 Mn
Sep 30, 2024 -7.14 Mn
Jun 30, 2024 -486,692.00
Mar 31, 2024 528,836.00
Dec 31, 2023 3.96 Mn
Sep 30, 2023 -2.46 Mn
Jun 30, 2023 -11.64 Mn
Mar 31, 2023 -1.55 Mn
Dec 31, 2022 -9,036.00
Sep 30, 2022 -8.75 Mn
Jun 30, 2022 -7.78 Mn
Mar 31, 2022 -9.61 Mn
Dec 31, 2021 -6.10 Mn
Sep 30, 2021 -6.68 Mn
Jun 30, 2021 -8.54 Mn